Medicare Advantage beneficiaries with cancer did not experience any difference in care quality despite having lower treatment costs than beneficiaries with traditional Medicare, according to a study published July 13 in JAMA Internal Medicine. Here are five notes from the…
Author: Elizabeth Gregerson
Chemotherapy drugs cisplatin, carboplatin, oxaliplatin and ifosfamide are in shortage again, but five health systems are managing without the treatment delays and drug rationing that defined 2023. Shortages of the drugs have been straining hospital supply chains since June, with…
Boston-based Dana-Farber Cancer Institute has filed a Determination of Need application with the Massachusetts Department of Public Health to reopen a radiation oncology clinic in partnership with Lawrence, Mass.-based Merrimack Health. The clinic would open on the Merrimack Health campus…
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center achieved an overall one-year survival rate of 92.6% after standardizing allogeneic hematopoietic cell transplant processes and workflows, according to a study published July 5 in Transplantation and Cellular Therapy. The most recent data…
Stanley Gartler, PhD, a molecular biologist, geneticist and cancer research “pioneer,” died May 25 at age 102, according to a July 4 report from The New York Times. Dr. Gartler was professor emeritus at the University of Washington in Seattle,…
Advertisement
With cancer care growing beyond hospital walls and more cancer patients surviving than ever before, health systems in the U.S. are doubling down on their oncology infrastructure commitments. “Cancer care can no longer be designed around treatment alone. We must…
Hartford, Conn.-based Trinity Health of New England has begun an assessment process with the intent of joining Boston-based Dana-Farber Cancer Institute’s Cancer Care Collaborative. If approved, Trinity Health of New England will become a member of the collaborative by January…
In 2025, the five-year cancer survival rate in the U.S. reached 70% for the first time — a milestone that translates to about 18.6 million cancer survivors. The growing cancer survivor population is pushing health systems to rethink what happens…
An AI framework can identify targets for CAR-T cell therapy in weeks, streamlining a process that often takes months to years, according to a study published June 25 in Cell. Here are three notes from the study: Read the full…
Boston-based Dana-Farber Cancer Institute’s $1.68 billion cancer hospital, currently under construction, will be named the Lavine Bekenstein Cancer Hospital at Dana-Farber. Dana-Farber President and CEO Benjamin Ebert, MD, PhD, shared the hospital’s official name June 25 on LinkedIn. The hospital…